Scholarly Index
Reijo Laaksonen
Zora Biosciences (Finland); 18,768 total citations; 319 total publications; best world rank #112
Zora Biosciences (Finland)
18,768Total citations
319Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lipoproteins and Cardiovascular Health | Lifetime | 620 | FI 20 | 97.53 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 908 | FI 10 | 94.89 |
| Sphingolipid Metabolism and Signaling | Lifetime | 519 | FI 12 | 92.94 |
| Coenzyme Q10 studies and effects | Lifetime | 763 | FI 5 | 78.63 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 112 | FI 1 | 86.30 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 865 | FI 14 | 84.89 |